You are here

Tumor Biology

Tumor Biology


eISSN: 14230380 | ISSN: 10104283 | Current volume: 42 | Current issue: 12 Frequency: Monthly
Tumor Biology is a peer reviewed, international journal providing an open access forum for experimental and clinical cancer research. It covers all aspects of tumor markers, molecular biomarkers, tumor targeting, and mechanisms of tumor development and progression.

Tumor Biology is a peer reviewed, international journal providing an open access forum for experimental and clinical cancer research. It covers all aspects of tumor markers, molecular biomarkers, tumor targeting, and mechanisms of tumor development and progression.

Specific topics of interest include, but are not limited to:

• Pathway analyses
• Non-coding RNAs
• Circulating tumor cells
• Liquid biopsies
• Exosomes
• Epigenetics
• Cancer stem cells
• Tumor immunology and immunotherapy
• Tumor microenvironment
• Targeted therapies
• Therapy resistance
• Cancer genetics
• Cancer risk screening.

Studies in other areas of basic, clinical, and translational cancer research are also considered in order to promote connections and discoveries across different disciplines.

The journal publishes original articles, reviews, commentaries, and guidelines on tumor marker use. All submissions are subject to rigorous peer review and are selected on the basis of whether the research is sound and deserves publication.

Tumor Biology is the official journal of the International Society of Oncology and BioMarkers (ISOBM).

Editor-in-Chief
Magdalena Chechlinska, PhD, Dr Habil Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Associate Editors
Changyan Chen Northeastern University, USA
Stefan Holdenrieder University of Bonn, Germany
Magdalena Kowalewska Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Salvatore Piscuoglio University Hospital Basel, Switzerland
Luca Quagliata Universitätsspital Basel, Switzerland
Marta Sanchez-Carbayo University of the Basque Country, Spain
EDITORIAL ADVISORY MEMBERS
Vivian Barak Hadassah Medical Center, Israel
Javier Castresana University of Navarra, Spain
Caroline Chapman University of Nottingham, UK
Chi Hin Cho The Chinese University of Hong Kong, Hong Kong, China
Jose Luis Costa University of Porto, Portugal
Elefterious Diamandis Mount Sinai Hospital, Canada
Joe Duffy UCD Dublin, Ireland
Sten Hammarström Umeå Universitet, Sweden
Kohzoh Imai The University of Tokyo, Japan
Chien-Feng (Angelo) Li Chi Mei Medical Center, Taiwan
Leendert H. J. Looijenga Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Andrea Nicolini University of Pisa, Italy
Barbara Pedley University College London, UK
Johanna (Hanny) M.A. Pijnenborg Radboud University Medical Center, The Netherlands
Ulf Hakan Stenman University of Helsinki, Finland
Iwona Wlodarska KU Leuven, Leuven, Belgium
  • Directory of Open Access Journals (DOAJ)
  • ProQuest
  • PubMed: MEDLINE
  • Scopus
  • From 1st January 2021, Tumor Biology will be published by IOS Press. This site is no longer accepting submissions, please submit your manuscript via https://www.editorialmanager.com/tub/

     

    For further information about IOS Press and Author Instructions please see https://www.iospress.nl/journal/tumor-biology/#submission-of-manuscript or contact editorial@iospress.nl.

    Subscription Information

     

    To subscribe to this journal or to purchase single/back issues, please contact Customer Service - Journals: customerservicejournals@sagepub.in  +91 (11) 4063 9222 extn 406


    To purchase bundled content, backfiles or any other electronic products, please contact: journalsales@sagepub.in


    For exciting offers and deals, write to: jmarketing@sagepub.in